June 2015 FDA Recall Drug by Mylan Pharmaceuticals Inc
D-1217-2015 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc on June 30, 2015 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1217-2015

Reason for Recall
Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.
Initiated
06-30-2015
Reported
07-15-2015
Quantity
1068 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Pharmaceuticals Inc
Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.

Batch or Lot Expiration Information

Lot# : 3053562, Exp 02/16